The Human Upgrade with Dave Asprey cover image

Muscle Preservation with GLP-1 Drugs - Dr. Anurag Singh : 1156

The Human Upgrade with Dave Asprey

NOTE

Understanding the Gut-Brain Axis: Dual Action of New Drugs

New drugs targeting glucagon-like peptides (GLP-1) effectively engage both the hormonal and reward pathways in the brain, influencing eating behaviors. By blocking glucagon secretion, these drugs help regulate cravings and prevent glucose spikes that typically drive hunger. This dual action promotes delayed gastric emptying, supporting anti-obesity and anti-diabetic effects. Their design capitalizes on the connection between gut hormones and brain reward systems, making them beneficial for managing weight and diabetes simultaneously.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner